-
Report: GNC may be looking to go public
PITTSBURGH — GNC is ready to pull the trigger on a long-anticipated initial public offering this Friday, according to several published reports.
It’ll be the third bite of the IPO apple for the Pittsburgh-based specialty chain. But if any time is a right time, that time is now, the company suggested in its prospectus, pointing to the graying of the baby boomer, coupled with increased pursuit of healthier lifestyles, which makes for a strong investment proposition for an already-established specialty channel retailer.
-
Dr. Reddy's completes acquisition of U.S. penicillin facility, products from GSK
HYDERABAD, India — Dr. Reddy’s Labs will assume ownership of a penicillin manufacturing site in Bristol, Tenn., from GlaxoSmithKline.
The generic drug maker said it completed the acquisition of the facility and related product portfolio, including Augmentin and Amoxil brands. GSK will retain the existing rights for the aforementioned brands outside the United States.
Further financial terms and conditions of the transaction are not being disclosed.